RSS   Newsletter   Contact   Advertise with us
Post Online Media

Intec Pharma appoints Jeffrey A. Meckler to board

Jeffrey A. MecklerIntec Pharma, a clinical stage biopharmaceutical company, announced the appointment of Jeffrey A. Meckler as vice chairman of its board of directors.

Mr. Meckler brings to Intec Pharma more than 25 years of life sciences executive experience.

Mr. Meckler spent more than 17 years at Pfizer, where he held leadership positions in corporate strategic planning, acquisitions and business development, market research, manufacturing systems and sales operations analysis.

Most recently, Mr. Meckler was Chief Executive Officer of Cocrystal Pharma, Inc.

Previously, Mr. Meckler was a director of QLT Inc., and initially the principal executive officer during its transformation into an orphan drug company.

He has served on numerous corporate boards and is currently a director of Retrophin, Inc.

Mr. Meckler earned his J.D. from Fordham University School of Law and is admitted to the New York Bar.

Mr. Meckler earned an M.S. in Industrial Administration and a B.S. in Industrial Management from Carnegie Mellon University.


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy